Large Noncoding RNAs as Therapeutic Targets in IPF
Abstract
Our proposal focuses on the role of FENDRR, a developmentally regulated lincRNA that controls gene expression by affecting chromatin remodeling in Pulmonary fibrosis (PF). PF is a condition in which the normal lung anatomy is replaced by a process of active remodeling, deposition of extracellular matrix (ECM) and accumulation of myofibroblasts. This condition can be idiopathic or secondary, but invariably associated with significant mortality and morbidity. In this project we test the hypothesis that FENDRR expression maintains fibroblasts differentiation status through its effects on chromatic organization, therefore when FENDRR expression is decreased, fibrosis is facilitated through persistence of myofibroblasts.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2018
- Accession Number
- AD1094683
Entities
People
- Naftali Kaminski
Organizations
- Yale University